Cohance Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03QK01018
  • NSEID: COHANCE
  • BSEID: 543064
INR
445.70
5.85 (1.33%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 39.92 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003386,
    "name": "Cohance Life",
    "stock_name": "Cohance Life",
    "full_name": "Cohance Lifesciences Ltd",
    "name_url": "stocks-analysis/cohance-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "445.70",
    "chg": 5.85,
    "chgp": "1.33%",
    "dir": 1,
    "prev_price": "439.85",
    "mcapval": "16,814.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543064,
    "symbol": "COHANCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE03QK01018",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "02:33 AM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "39.92 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cohance Lifesciences Ltd Technical Momentum Shifts Amid Bearish Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-technical-momentum-shifts-amid-bearish-sentiment-4141062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CohanceLifescie_technicaldot_4141062.png",
        "date": "2026-08-07 08:05:53",
        "description": "Cohance Lifesciences Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent uptick in price, the company’s overall technical indicators and fundamental metrics continue to signal caution for investors amid a challenging market backdrop."
      },
      {
        "title": "Cohance Lifesciences Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-faces-bearish-momentum-amid-technical-downgrade-4135328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CohanceLifescie_technicaldot_4135328.png",
        "date": "2026-08-04 08:10:01",
        "description": "Cohance Lifesciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite minor intraday fluctuations, the stock remains under pressure, reflecting broader challenges within the Pharmaceuticals & Biotechnology sector and its small-cap status."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-strong-sell-4132272",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CohanceLifescie_mojoScore_4132272.png",
        "date": "2026-08-02 10:10:28",
        "description": "Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-strong-sell-4115063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CohanceLifescie_mojoScore_4115063.png",
        "date": "2026-07-22 10:11:01",
        "description": "Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-strong-sell-4096940",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CohanceLifescie_mojoScore_4096940.png",
        "date": "2026-07-11 10:10:32",
        "description": "Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 May 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 11 July 2026, providing investors with the latest insights into its performance and valuation."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-strong-sell-4078698",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_mojoScore_4078698.png",
        "date": "2026-06-30 10:10:55",
        "description": "Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 May 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 30 June 2026, providing investors with the latest view of the company’s position in the market."
      },
      {
        "title": "Cohance Lifesciences Gains 12.87%: 3 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-gains-1287-3-key-factors-driving-the-surge-4075165",
        "imagepath": "",
        "date": "2026-06-27 12:00:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>22 Jun:</strong> Stock opens at Rs.406.25 with modest gains</p>\n                    <p><strong>23 Jun:</strong> Intraday high and upper circuit hit at Rs.486.30</p>\n                    <p><strong>24 Jun:</strong> Continued gains with moderate volume</p>\n                    <p><strong>25 Jun:</strong> Slight profit booking closes week at Rs.457.95</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.405.75</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.457.95</div><div class=\"stat-chang..."
      },
      {
        "title": "Cohance Lifesciences Ltd Locks at Upper Circuit With 16.13% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-surges-to-upper-circuit-on-robust-buying-pressure-4069159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_stocks_hitting_upper_circuit_4069159.png",
        "date": "2026-06-23 12:00:13",
        "description": "At Rs 486.3, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Cohance Lifesciences Ltd locked at its upper circuit of 20% on 23 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Cohance Lifesciences Ltd Sees Surge in Value Trading Amid Volatility and Institutional Caution",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-sees-surge-in-value-trading-amid-volatility-and-institutional-caution-4069118",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_most_active_equities_by_value_4069118.png",
        "date": "2026-06-23 11:00:11",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable spike in trading activity on 23 June 2026, with total traded value nearing ₹499.6 crores and volume exceeding 1.11 crore shares. The stock outperformed its sector by 11.7% and reversed a four-day losing streak, signalling renewed investor interest despite its strong sell rating and recent downgrade by MarketsMOJO."
      }
    ],
    "total": 583,
    "sid": "1003386",
    "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Aug-2026",
      "details": "Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of The Board Meeting",
      "datetime": "05-Aug-2026",
      "details": "Outcome of the Board Meeting",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
      "datetime": "05-Aug-2026",
      "details": "Outcome of the Board Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20",
          "dt": "2020-09-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Aug-2026 | Source : BSE

Newspaper Publication

Outcome Of The Board Meeting

05-Aug-2026 | Source : BSE

Outcome of the Board Meeting

Board Meeting Outcome for Outcome Of The Board Meeting

05-Aug-2026 | Source : BSE

Outcome of the Board Meeting

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Cohance Lifesciences Ltd has declared 100% dividend, ex-date: 09 Sep 22

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Cohance Lifesciences Ltd has announced 1:1 bonus issue, ex-date: 25 Sep 20

stock-summary
RIGHTS

No Rights history available